Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoenolpyruvate carboxykinase (PEPCK) is a key enzyme in gluconeogenesis, catalyzing the conversion of oxaloacetate to phosphoenolpyruvate. It exists in cytosolic (PEPCK-C) and mitochondrial (PEPCK-M) isoforms, playing crucial roles in glucose homeostasis, glyceroneogenesis, and amino acid metabolism. Dysregulation of PEPCK is implicated in metabolic disorders such as type 2 diabetes and hypoglycemia, making it a potential therapeutic target.
Inhibition of PEPCK activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoenolpyruvate Carboxykinase (PEPCK).